Profile	GDS3514 / 202506_at
Title	Liposarcoma response to doxorubicin in vitro
Organism	Homo sapiens

Graph caption help

Sample	Title	Value	Rank
GSM325240	Patient no. 1: control	2049.37	85
GSM325241	Patient no. 1: treated	1649.15	82
GSM325242	Patient no. 9: control	3273.1	91
GSM325243	Patient no. 9: treated	3810.21	92
GSM325244	Patient no. 18: control	2038.35	86
GSM325245	Patient no. 18: treated	1966.45	85
GSM325246	Patient no. 12: control	2162.04	86
GSM325247	Patient no. 12: treated	1436.47	81
GSM325248	Patient no. 3: control	2051.17	85
GSM325249	Patient no. 3: treated	1959.15	84
GSM325250	Patient no. 7: control	1055.41	76
GSM325251	Patient no. 7: treated	1256.37	79
GSM325252	Patient no. 15: control	1915.52	85
GSM325253	Patient no. 15: treated	1597.74	82
GSM325254	Patient no. 4: control	1690.8	83
GSM325255	Patient no. 4: treated	1569.04	81
GSM325256	Patient no. 19: control	1967.92	85
GSM325257	Patient no. 19: treated	1745.63	83
GSM325258	Patient no. 14: control	527.691	60
GSM325259	Patient no. 14: treated	533.715	59
GSM325260	Patient no. 13: control	1463.59	80
GSM325261	Patient no. 13: treated	1539.4	81
GSM325262	Patient no. 17: control	1366.54	78
GSM325263	Patient no. 17: treated	1906	85
GSM325264	Patient no. 10: control	1130.39	76
GSM325265	Patient no. 10: treated	1383.22	79
GSM325266	Patient no. 5: control	1901.5	83
GSM325267	Patient no. 5: treated	1560.75	82
GSM325268	Patient no. 11: control	1491.86	80
GSM325269	Patient no. 11: treated	1779.57	83
GSM325270	Patient no. 6: control	5820.29	95
GSM325271	Patient no. 6: treated	1157.83	78
GSM325272	Patient no. 8: control	1429.38	80
GSM325273	Patient no. 8: treated	1304.97	79
GSM325274	Patient no. 16: control	1292.97	78
GSM325275	Patient no. 16: treated	2367.46	87
GSM325276	Patient no. 2: control	1551.45	80
GSM325277	Patient no. 2: treated	733.293	70